Amanote Research
Register
Sign In
Molybdenum-Catalyzed Asymmetric Allylation of 3-Alkyloxindoles: Application to the Formal Total Synthesis of (-)-Physostigmine
doi 10.1021/ja060560j.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?
Cancer
Cancer Research
Oncology
Is There Light at the End of the Tunnel?
Anesthesia and Analgesia
Anesthesiology
Pain Medicine
Selinexor, a First-In-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients With Myelodysplastic Syndromes Refractory to Hypomethylating Agents
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Six (Or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes
Seminars in Oncology
Oncology
Hematology
Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents
Current Opinion in Hematology
Hematology
Tracheal Transplantation: Is There Lumen at the End of the Tunnel?
Sao Paulo Medical Journal
Medicine
Plasma Exchange for Acute on Chronic Liver Failure: Is There a Light at the End of the Tunnel?
Hepatology International
Hepatology
Chronic Total Occlusions--A Stiff Challenge Requiring a Major Breakthrough: Is There Light at the End of the Tunnel?
Heart
Cardiovascular Medicine
Cardiology
The Unified Patent Court: Pros and Cons of Specialization – Is There a Light at the End of the Tunnel (Vision)?
IIC International Review of Intellectual Property and Competition Law
Law
International Relations
Political Science
